CME Group (CME)
(Delayed Data from NSDQ)
$223.57 USD
-1.71 (-0.76%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $223.60 +0.03 (0.01%) 5:24 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Price, Consensus and EPS Surprise
CME 223.57 -1.71(-0.76%)
Will CME be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for CME based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CME
Nasdaq Trading Near 52-Week High: How Should You Play the Stock?
Why Investors Need to Take Advantage of These 2 Finance Stocks Now
CME: What are Zacks experts saying now?
Zacks Private Portfolio Services
How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings
Bitcoin Surges Ahead of Fed Rate Cut: 5 Crypto-Centric Stocks to Gain
Zacks Industry Outlook Intercontinental Exchange, CME Group, Nasdaq, Cboe Global and MarketAxess
Other News for CME
CME to launch options E-mini Select Sector futures, US real estate index futures
CME posts record quarterly, September ADV with broad asset class growth
CME Group reports Q3, September market statistics
CME Group Posts Record Q3 and September Volume
CME Group Expands Nikkei Futures Offerings, Boosts Japanese Equity Derivatives